Melissa Alegre, Ph.D. - Publications
Affiliations: | 2013 | Molecular Biology | Brigham Young University, Provo, UT, United States |
Area:
OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Xiao M, Helsing AV, Lynch PM, El-Naggar A, Alegre MM, Robison RA, O'Neill KL. DNA damage caused by inorganic particulate matter on Raji and HepG2 cell lines exposed to ultraviolet radiation. Mutation Research. Genetic Toxicology and Environmental Mutagenesis. 771: 6-14. PMID 25308436 DOI: 10.1016/J.Mrgentox.2014.06.004 | 0.384 | |||
2014 | Alegre MM, Weyant MJ, Bennett DT, Yu JA, Ramsden MK, Elnaggar A, Robison RA, O'Neill KL. Serum detection of thymidine kinase 1 as a means of early detection of lung cancer. Anticancer Research. 34: 2145-51. PMID 24778016 | 0.446 | |||
2013 | Alegre MM, Knowles MH, Robison RA, O'Neill KL. Mechanics behind breast cancer prevention - focus on obesity, exercise and dietary fat. Asian Pacific Journal of Cancer Prevention : Apjcp. 14: 2207-12. PMID 23725113 DOI: 10.7314/Apjcp.2013.14.4.2207 | 0.437 | |||
2013 | Alegre MM, Robison RA, O'Neill KL. Thymidine Kinase 1: A Universal Marker for Cancer Cancer and Clinical Oncology. 2. DOI: 10.5539/Cco.V2N1P159 | 0.483 | |||
2012 | Alegre MM, Robison RA, O'Neill KL. Thymidine kinase 1 upregulation is an early event in breast tumor formation. Journal of Oncology. 2012: 575647. PMID 22778736 DOI: 10.1155/2012/575647 | 0.461 | |||
2012 | Alegre M, Germann BL, Leavitt M, Eggett D, Killpack N, Burton S, Orton A, Leavitt C, O'Neill KL. Abstract 5528: Setting the clock: Tumor TK1 is a prognostic marker for disease recurrence Cancer Research. 72: 5528-5528. DOI: 10.1158/1538-7445.Am2012-5528 | 0.359 | |||
Show low-probability matches. |